Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
ImmunoTargets and Therapy
Volume 13, 2024 - Issue
ORIGINAL RESEARCH
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis
Kaiwu Xu1 Department of Gastrointestinal Surgery, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan Province, 410005, People’s Republic of China
https://orcid.org/0000-0001-7125-900X
https://orcid.org/0000-0001-7125-900X, Cailing Xiang1 Department of Gastrointestinal Surgery, Hunan Provincial People’s Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan Province, 410005, People’s Republic of Chinahttps://orcid.org/0000-0001-7206-3463
https://orcid.org/0000-0001-7206-3463, , &